RINVOQ FDA approval date

The FDA approved RINVOQ on 16 Aug 2019.

FDA approval date
16 Aug 2019

Drug identity has not yet been verified against registry records

Also recorded as UPADACITINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-08-16DayRINVOQFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211675", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["RINVOQ"], "active_ingredients": ["UPADACITINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190816", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026